Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02741648 · ClinicalTrials.gov registry record
RBC Irradiation, Anemia and Gut Injury
A clinical trial of Anemia and Necrotizing Enterocolitis, sponsored by Emory University.
- Active
- Registry status
- 324
- Enrollment target
- 3
- Study locations
NCT02741648 is a study of Anemia and Necrotizing Enterocolitis that is active but no longer recruiting, run by Emory University. The registered enrollment target is 324 participants, below the 423-participant average among 72 other Anemia trials with a reported enrollment target (23% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT02741648, a study of Anemia and Necrotizing Enterocolitis, is active but no longer recruiting, sponsored by Emory University.
- ACTIVE NOT RECRUITING
- Registry status
- 324 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this trial is to study the effect that anemia and red blood cell (RBC) transfusions have on oxygen levels in the digestive tracts of extremely low birth weight (ELBW) infants and to look for possible markers in a baby's blood, urine and/or stool that may lead to a better understanding of what makes an ELBW infant at risk for digestive tract problems such as necrotizing enterocolitis.
Conditions Studied
Interventions
- DEVICE Near Infrared Spectroscopy
- OTHER Non-invasive Image-based Anemia Assessment
Study Locations (3)
Georgia
- Grady Memorial Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
- Northside Hospital - Neonatology - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2016-07 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02741648
The ClinicalTrials.gov registry entry for NCT02741648 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 423-participant average among 72 other Anemia trials with a reported enrollment target (23% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Near Infrared Spectroscopy is the first listed.
NCT02741648 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02741648 about?
NCT02741648 is a clinical study titled "RBC Irradiation, Anemia and Gut Injury". The purpose of this trial is to study the effect that anemia and red blood cell (RBC) transfusions have on oxygen levels in the digestive tracts of extremely low birth weight (ELBW) infants and to look for possible markers in a baby's blood, urine and/or stool that may lead to a better understanding...
What is the current status of trial NCT02741648?
This trial is currently active not recruiting. The enrollment target is 324 participants. The study started on 2016-07. Estimated completion is 2026-02-28.
What conditions does trial NCT02741648 study?
This clinical trial studies the following conditions: Anemia, Necrotizing Enterocolitis.
What interventions are being tested in trial NCT02741648?
The interventions under investigation include: Near Infrared Spectroscopy (DEVICE), Non-invasive Image-based Anemia Assessment (OTHER).
Who is sponsoring clinical trial NCT02741648?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02741648 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RECRUITING · Phase 1
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RECRUITING · Phase 3
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.